NCT03959839

Brief Summary

A multicenter non-inferiority randomized clinical trial to compare Endoscopic treatment (ESD) and Minimally Invasive Laparoscopic Local Surgical Treatment (TAMIS or TEO) for early rectal neoplastic lesions (adenoma \& T1CRC) Primary aim: To compare the long-term local recurrence rate (12 months after the procedure) Secondary aims: Compare en-bloq resection rate, R0 resection, time per procedure, short-term recurrence rate, safety (rate of complications), morbidity and cost-effectiveness analyses.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2019

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

May 16, 2019

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 22, 2019

Completed
5.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2024

Completed
Last Updated

June 3, 2025

Status Verified

May 1, 2025

Enrollment Period

5.7 years

First QC Date

May 16, 2019

Last Update Submit

May 28, 2025

Conditions

Keywords

Early Rectal NeoplasmsESDTAMISTEORecurrenceR0Safety

Outcome Measures

Primary Outcomes (1)

  • local recurrence rate

    presence of remaining neoplastic tissue in resection site

    12 months

Secondary Outcomes (9)

  • En-bloq resection rate

    1 hour

  • R0 resection rate

    1 hour

  • Time per procedure

    1 hour

  • Length of hospital stay

    1 hour

  • Early complications rate

    1 hour

  • +4 more secondary outcomes

Study Arms (2)

Endoscopic Treatment

EXPERIMENTAL

Rectal Endoscopic Submucosal Dissection

Procedure: ESD

Minimally Invasive Laparoscopic Local Surgical Treatment

EXPERIMENTAL

Transanal Minimally Invasive Surgery (TAMIS) or Transanal Endoscopic Operation (TEO)

Procedure: TAMISProcedure: TEO

Interventions

ESDPROCEDURE

Rectal Endoscopic Submucosal Dissection

Endoscopic Treatment
TAMISPROCEDURE

Transanal Minimally Invasive Surgery

Minimally Invasive Laparoscopic Local Surgical Treatment
TEOPROCEDURE

Transanal Endoscopic Operation

Minimally Invasive Laparoscopic Local Surgical Treatment

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients older than 18 y/o
  • Non-pedunculated rectal lesions (sessile 0-Is or flat 0-II) greater than 20 mm in diameter.
  • The edges of the lesion should be more than 3 cm from the external anal margin and up to 14 cm from it.
  • Circumferential involvement \<50%

You may not qualify if:

  • Patients who refuse to participate.
  • Diagnosis of inflammatory bowel disease with rectal involvement.
  • Pregnant.
  • Anorectal fibrosis due to previous anorectal surgery.
  • Lateral Spreading Lesions (LST classification) Granular Homogeneous type
  • Lesions greater than 50 mm when there is suspicion of advanced histology (Kudo Vi superficial pattern).
  • Rectal lesions of any size with high suspicion of deep submucosal invasion or locoregional lymph node involvement, either in the diagnostic colonoscopy (Kudo Vn pit pattern, NICE 3 pattern, Sano IIIB pattern) or by complementary imaging tests (rectal EUS/Pelvic MRI)
  • Existence of synchronous colorectal lesions that require other surgical treatment in any case.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Hospital de Sant Joan Despí Moisès Broggi

Barcelona, Barcelona, Spain

Location

Hospital General Universitario Gregorio Marañón

Madrid, Madrid, Spain

Location

Hospital Universitario Puerta de Hierro

Majadahonda, Madrid, 28222, Spain

Location

Related Publications (1)

  • de Frutos Rosa D, Alonso Sebastian I, Barquero Declara D, Badia Closa J, Nogales O, Jimenez Gomez LM, Santiago Garcia J, Valentin Gomez F, Royuela Vicente A, Sanchez Movilla A, Albeniz E, Herreros de Tejada Echanojauregui A; Mucosal Resection; Third-Space Endoscopy Working Group from the Spanish Society of Gastrointestinal Endoscopy. A Randomized Trial of Endoscopic Submucosal Dissection vs Transanal Minimally Invasive Surgery in Early Rectal Neoplasms: DSETAMIS-2018 Study. Gastroenterology. 2026 Jan;170(1):161-173. doi: 10.1053/j.gastro.2025.07.029. Epub 2025 Jul 30.

MeSH Terms

Conditions

Rectal NeoplasmsRecurrence

Interventions

Transanal Endoscopic Surgery

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesIntestinal DiseasesRectal DiseasesDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Natural Orifice Endoscopic SurgeryEndoscopyDiagnostic Techniques, SurgicalDiagnostic Techniques and ProceduresDiagnosisProctoscopyEndoscopy, GastrointestinalEndoscopy, Digestive SystemDigestive System Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical Procedures

Study Officials

  • Eduardo Albéniz, MD, PhD

    Complejo Hospitalario de Navarra

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 16, 2019

First Posted

May 22, 2019

Study Start

April 1, 2019

Primary Completion

December 20, 2024

Study Completion

December 20, 2024

Last Updated

June 3, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations